Xianrui Wu
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 5
- Oncology top 5%
- Colorectal Cancer Surgical Treatments 13
- Cancer Immunotherapy and Biomarkers 8
- Physiology top 5%
- Immunology top 5%
- Immune Cell Function and Interaction 5
- Molecular Biology top 10%
-
- Inflammatory Bowel Disease 21
-
- Microscopic Colitis 9
-
- Diverticular Disease and Complications 6
- Anorectal Disease Treatments and Outcomes 5
- Cited by
- Cancer ResearchOncologyPhysiology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xianrui Wu
88 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 805
- Oncology 713
- Physiology 107
- Immunology 480
- Molecular Biology 1.3k
Countries citing papers authored by Xianrui Wu
This map shows the geographic impact of Xianrui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianrui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianrui Wu more than expected).
Fields of papers citing papers by Xianrui Wu
This network shows the impact of papers produced by Xianrui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianrui Wu. The network helps show where Xianrui Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianrui Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell deathbreakdown → | 2024 | 62 |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 16 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 145 | |
| 10 | 2021 | 30 | |
| 11 | 2020 | 195 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 267 | |
| 14 | 2018 | 11 | |
| 15 | 2017 | 21 | |
| 16 | 2015 | 15 | |
| 17 | 2015 | 6 | |
| 18 | 2014 | 29 | |
| 19 | 2013 | 16 | |
| 20 | 2012 | 15 |
About Xianrui Wu
Xianrui Wu is a scholar working on Oncology, Gastroenterology and Immunology, having authored 93 papers that have together received 2.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (21 papers), Colorectal Cancer Surgical Treatments (13 papers), Microscopic Colitis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Diverticular Disease and Complications (6 papers), Anorectal Disease Treatments and Outcomes (5 papers), Cancer Genomics and Diagnostics (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Cancer Research (805 citations), Oncology (713 citations) and Physiology (107 citations). Xianrui Wu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ping Lan, Tuo Hu, Zhenxing Liang, Huashan Liu, Xiaowen He, Chi Zhou, Bo Shen, Xiaosheng He, Li Xiong and Xiaojian Wu. Their work appears in journals such as Nature Communications, Gastroenterology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.